Stock Spotlight: Tenet Healthcare (THC)

Avatar photo

Tenet Healthcare Corporation (THC) reported second-quarter earnings of $2.31 per share, exceeding the consensus estimate of $1.89 by 22.2%. This marks the 18th consecutive quarter the company has surpassed earnings estimates. Analysts have increased their third-quarter earnings expectations by 10.95%, with the current Zacks Consensus EPS Estimate standing at $2.33 per share, projecting a 61.8% growth from the previous year.

THC’s stock has significantly outperformed the market this year, advancing over 115% and reaching multiple 52-week highs, largely due to its strong performance in the top-ranked Zacks Medical – Hospital industry group. The company attributes this growth to rising patient admissions, emergency room visits, and surgeries, and aims to expand through acquisitions and alliances.

With strong fundamentals and a favorable ranking in Zacks Style Scores for Value and Momentum, Tenet Healthcare is positioned for continued growth as it maintains a robust technical trend, supported by a history of earnings beats and active revisions of positive earnings estimates.

5 Stocks Our Experts Predict Could Double In the Next Year

By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.

The free Daily Market Overview 250k traders and investors are reading

Read Now